Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis.

International journal of medical sciences - 1 Jan 2024

Zhao Xiaojie, Yu Xin, Li Wenge, Chen Zhiyuan, Niu Tingting, Weng Xiaodong, Wang Lei, Liu Xiuheng

Abstract excerpt

Background: CDK6 is linked to tumor progression and metastasis, although its molecular mechanism and prognostic value are unclear in bladder cancer. Materials and methods: In our study, raw data were obtained from public databases and Single-center retrospective case series. We conducted a bioinformatics analysis and immunohistochemistry to explore the biological landscape of CDK6 in tumors, with a particular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase 6

Share to Gene Expression Regulation, Neoplastic

Share to Immunohistochemistry

Share to Immunotherapy

Share to Tumor Microenvironment

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39310261
DOI: 10.7150/ijms.101043
PMCID: PMC11413897

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis.PMID 39310261Read ↗

Molecular Landscape of Bladder Cancer: Key Genes, Transcription Factors, and Drug InteractionsSemantic proximity Read ↗

Significance of KDM6A Mutation in Bladder Cancer Immune EscapeSemantic proximity Read ↗

Significance of KDM6A Mutation in Bladder Cancer Immune EscapeSemantic proximity Read ↗

Significance of KDM6A mutation in bladder cancer immune escape.Semantic proximity Read ↗

Integrative In Silico Transcriptomic and Pharmacogenomic Analysis of CD276 as a Candidate Prognostic Biomarker and Therapeutic Target in Bladder CancerSemantic proximity Read ↗

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentSemantic proximity Read ↗

Comprehensive analysis of cyclin-dependent kinase 6 and its correlation with immune infiltration in uterine corpus endometrial carcinomaSemantic proximity Read ↗

TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics studySemantic proximity Read ↗

Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental AssaysSemantic proximity Read ↗

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO DataSemantic proximity Read ↗

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancerSemantic proximity Read ↗

In silico analysis and validation of the cancer-associated fibroblasts-related gene CAMK4 promotes bladder cancer progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.